These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38890737)

  • 1. Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma.
    Liu J; Li X; Chen J; Guo J; Guo H; Zhang X; Fan J; Zhang K; Mao J; Zhou B
    J Nanobiotechnology; 2024 Jun; 22(1):338. PubMed ID: 38890737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STING agonist-based hydrogel enhances immune activation in synergy with radiofrequency ablation for hepatocellular carcinoma treatment.
    Ao F; Li X; Tan Y; Jiang Z; Yang F; Guo J; Zhu Q; Chen Z; Zhou B; Zhang K; Li D
    J Control Release; 2024 May; 369():296-308. PubMed ID: 38301925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of OK-432 in combination with an anti-PD-1 antibody for residual tumors after radiofrequency ablation of hepatocellular carcinoma.
    Sun T; Sun B; Cao Y; Liu J; Chen J; Liang B; Zheng C; Kan X
    Biomed Pharmacother; 2023 Oct; 166():115351. PubMed ID: 37625323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation.
    Cao Y; Sun T; Sun B; Zhang G; Liu J; Liang B; Zheng C; Kan X
    J Nanobiotechnology; 2023 Nov; 21(1):404. PubMed ID: 37919724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insufficient radiofrequency ablation-induced autophagy contributes to the rapid progression of residual hepatocellular carcinoma through the HIF-1α/BNIP3 signaling pathway.
    Xu WL; Wang SH; Sun WB; Gao J; Ding XM; Kong J; Xu L; Ke S
    BMB Rep; 2019 Apr; 52(4):277-282. PubMed ID: 30940322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
    Chen X; Huang Y; Chen H; Chen Z; Chen J; Wang H; Li D; Su Z
    J Nanobiotechnology; 2022 Jan; 20(1):34. PubMed ID: 35033089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete radiofrequency ablation induced chemoresistance by up-regulating heat shock protein 70 in hepatocellular carcinoma.
    Wang F; Xu C; Li G; Lv P; Gu J
    Exp Cell Res; 2021 Dec; 409(2):112910. PubMed ID: 34801560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size-Tunable Nanoregulator-Based Radiofrequency Ablation Suppresses MDSCs and Their Compensatory Immune Evasion in Hepatocellular Carcinoma.
    Tang Y; Shu Z; Zhu M; Li S; Ling Y; Fu Y; Hu Z; Wang J; Yang Z; Liao J; Xu L; Yu M; Peng Z
    Adv Healthc Mater; 2023 Dec; 12(30):e2302013. PubMed ID: 37665720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient radiofrequency ablation promotes proliferation of residual hepatocellular carcinoma via autophagy.
    Zhao Z; Wu J; Liu X; Liang M; Zhou X; Ouyang S; Yao J; Wang J; Luo B
    Cancer Lett; 2018 May; 421():73-81. PubMed ID: 29458142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium Complex Suppresses Proliferation of Residual Hepatocellular Carcinoma after Incomplete Radiofrequency Ablation Therapy.
    Yu ZJ; Guo SW; Wang BS; Ouyang S; Zhang XH; Zhao ZZ; Wang JQ
    Recent Pat Anticancer Drug Discov; 2024 Aug; ():. PubMed ID: 39136523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation inhibitors activate anti-tumor immunity by reshaping the immune microenvironment in a preclinical model of hepatocellular carcinoma.
    Wang Z; Pan B; Su L; Yu H; Wu X; Yao Y; Zhang X; Qiu J; Tang N
    Cell Oncol (Dordr); 2024 Apr; 47(2):513-532. PubMed ID: 38055116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The HSP90 inhibitor, XL888, enhanced cell apoptosis via downregulating STAT3 after insufficient radiofrequency ablation in hepatocellular carcinoma.
    Sun C; Bai M; Ke W; Wang X; Zhao X; Lu Z
    Life Sci; 2021 Oct; 282():119762. PubMed ID: 34186047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins.
    Zhang N; Li H; Qin C; Ma D; Zhao Y; Zhu W; Wang L
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):895-907. PubMed ID: 30820716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting PI3Kγ/AKT Pathway Remodels LC3-Associated Phagocytosis Induced Immunosuppression After Radiofrequency Ablation.
    Liu X; Zhang W; Xu Y; Xu X; Jiang Q; Ruan J; Wu Y; Zhou Y; Saw PE; Luo B
    Adv Sci (Weinh); 2022 Mar; 9(7):e2102182. PubMed ID: 35037422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence.
    Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K
    Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy-amplifying nanoparticles evoke immunogenic cell death combined with anti-PD-1/PD-L1 for residual tumors immunotherapy after RFA.
    Zhang S; Huang Y; Pi S; Chen H; Ye F; Wu C; Li L; Ye Q; Lin Y; Su Z
    J Nanobiotechnology; 2023 Oct; 21(1):360. PubMed ID: 37789342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation.
    Huang T; Wu W; Wu J; Tan Y; Zhang M; Long H; Guo H; Zhang X; Zhou W; Zhang Q; Xie X; Xu M; Zhang C
    Front Immunol; 2023; 14():1124152. PubMed ID: 37051250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insufficient radiofrequency ablation promotes hepatocellular carcinoma cell progression via autophagy and the CD133 feedback loop.
    Wang X; Deng Q; Feng K; Chen S; Jiang J; Xia F; Ma K; Bie P
    Oncol Rep; 2018 Jul; 40(1):241-251. PubMed ID: 29749472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
    Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
    J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-α Combined With Herbal Compound "Songyou Yin" Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal Model.
    Zhang N; Wang LR; Li DD; Ma DN; Wang CH; He XG; Gao DM; Wang L; Tang ZY
    Integr Cancer Ther; 2018 Dec; 17(4):1260-1269. PubMed ID: 30234394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.